Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: sodium hydroxide; mannitol; povidone; lactose monohydrate; meglumine; magnesium stearate; sodium stearylfumarate; purified water; iron oxide red - mizart hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: meglumine; lactose monohydrate; povidone; magnesium stearate; crospovidone; colloidal anhydrous silica; sodium hydroxide - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: magnesium stearate; crospovidone; lactose monohydrate; meglumine; colloidal anhydrous silica; sodium hydroxide; povidone - telmisartan is indicated for:,treatment of hypertension ,prevention of cardiovascular morbidity and mortality in patients 55 years or older with,coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic,attack or high risk diabetes with evidence of end organ damage.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: magnesium stearate; purified water; povidone; sodium stearylfumarate; mannitol; sodium hydroxide; meglumine; lactose monohydrate; iron oxide red - teltartan hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; magnesium stearate; meglumine; sorbitol; povidone - the proposed indications are identical to those for the approved innovator product; based on the latest published micardis pi (most recent amendment jan11) the indications are (i) treatment of hypertension, and (ii) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; magnesium stearate; meglumine; sorbitol; povidone - the proposed indications are identical to those for the approved innovator product; based on the latest published micardis pi (most recent amendment jan11) the indications are (i) treatment of hypertension, and (ii) prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: mannitol; meglumine; povidone; potassium hydroxide; magnesium stearate - treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: sodium hydroxide; povidone; meglumine; mannitol; magnesium stearate - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: magnesium stearate; meglumine; mannitol; sodium hydroxide; povidone - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg - tablet - excipient ingredients: meglumine; sodium hydroxide; magnesium stearate; mannitol; povidone - telmisartan is indicated for: treatment of hypertension. prevention of cardiovascular morbidity and mortality in patients 55 years or older with coronary artery disease, peripheral artery disease, previous stroke, transient ischaemic attack or high risk diabetes with evidence of end organ damage (see clinical trials).